These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin]. Kudriashov BA; Pastorova VE; Liapina LA Biokhimiia; 1981 Nov; 46(11):2024-9. PubMed ID: 7317530 [TBL] [Abstract][Full Text] [Related]
4. [Heparin and antithrombin consumption]. BURSTEIN M; GUINAND A Arch Int Pharmacodyn Ther; 1956 Jan; 104(3-4):435-44. PubMed ID: 13314711 [No Abstract] [Full Text] [Related]
5. [Mechanism of action of heparin as antithrombin and dynamics of fibrin formation]. AMANN R; WERLE E Klin Wochenschr; 1957 Jan; 35(1):22-6. PubMed ID: 13417492 [No Abstract] [Full Text] [Related]
6. Studies on an antithrombin. III. A plasma antithrombin test for the prediction of intravascular clotting. KAY JH; HUTTON SB; WEISS GN; OCHSNER A Surgery; 1950 Jul; 28(1):24-8. PubMed ID: 15442785 [No Abstract] [Full Text] [Related]
7. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594 [TBL] [Abstract][Full Text] [Related]
8. The existence of variations in the ease with which thrombin preparations may be inactivated by antithrombin. CARTER JR; SMITH HP Fed Proc; 1946; 5(1 Pt 2):219. PubMed ID: 20984560 [No Abstract] [Full Text] [Related]
9. Antithrombin as substrate for the enzyme thrombin. SEEGERS WH; YOSHINARI M; LANDABURU RH Thromb Diath Haemorrh; 1960 Jun; 4():293-8. PubMed ID: 14444479 [No Abstract] [Full Text] [Related]
11. By increasing the affinity of heparin for fibrin, Zn(2+) promotes the formation of a ternary heparin-thrombin-fibrin complex that protects thrombin from inhibition by antithrombin. Chan HH; Leslie BA; Stafford AR; Roberts RS; Al-Aswad NN; Fredenburgh JC; Weitz JI Biochemistry; 2012 Oct; 51(40):7964-73. PubMed ID: 22978548 [TBL] [Abstract][Full Text] [Related]
12. Sensitivity of thrombin and plasmin to heparin and antithrombin III. Bauer PI; Breuer Z; Machovich R; Büki KG; Horváth I Acta Biochim Biophys Acad Sci Hung; 1985; 20(3-4):155-61. PubMed ID: 2944348 [TBL] [Abstract][Full Text] [Related]
13. [A method for isolated determination of thrombin inhibitor and antithrombin]. WITTE S; DIRNBERGER P Klin Wochenschr; 1953 Jul; 31(25-26):598-600. PubMed ID: 13097856 [No Abstract] [Full Text] [Related]
14. [Clinical significance of antithrombin]. GRUNING W; BORN H Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1953; 275(7):556-66. PubMed ID: 13131885 [No Abstract] [Full Text] [Related]
15. Antithrombin III. Theory and clinical applications. H. P. Smith Memorial Lecture. Seegers WH Am J Clin Pathol; 1978 Apr; 69(4):299-359. PubMed ID: 347919 [TBL] [Abstract][Full Text] [Related]
16. Hyperproduction of fibrin and inefficacy of antithrombin III and alpha2 macroglobulin in the presence of bacterial porins. Di Micco B; Di Micco P; Lepretti M; Stiuso P; Donnarumma G; Iovene MR; Capasso R; Tufano MA Int J Exp Pathol; 2005 Aug; 86(4):241-5. PubMed ID: 16045546 [TBL] [Abstract][Full Text] [Related]
18. [DIFFERENTIATION OF THE INHIBITORS OF THE CONVERSION OF FIBRINOGEN INTO FIBRIN]. VERMYLEN C; VERSTRAETE M Nouv Rev Fr Hematol; 1965; 5():376-82. PubMed ID: 14307711 [No Abstract] [Full Text] [Related]
19. Relationship between antithrombin and thrombin levels in plasma and serum. MONKHOUSE FC Am J Physiol; 1959 Nov; 197():984-8. PubMed ID: 14423576 [No Abstract] [Full Text] [Related]
20. [Some new data on antithrombin V]. VERMYLEN C; VERSTRAETE M Belg Tijdschr Geneesk; 1961 Aug; 17():825-34. PubMed ID: 13780944 [No Abstract] [Full Text] [Related] [Next] [New Search]